Department of Paediatrics, The First Affiliated Hospital of Anhui Medical University, No. 218 Ji-Xi Road, Hefei, 230022, Anhui Province, People's Republic of China.
Clin Exp Med. 2024 Aug 6;24(1):177. doi: 10.1007/s10238-024-01430-z.
Coagulation disorders are common in Kawasaki disease (KD). The main objectives of the present study were to probe the associations of coagulation profiles with clinical classification, IVIG responsiveness, coronary artery abnormalities (CAAs) in the acute episode of KD. A total of 313 KD children were recruited and divided into six subgroups, including complete KD (n = 217), incomplete KD (n = 96), IVIG-responsive KD (n = 293), IVIG-nonresponsive KD (n = 20), coronary artery noninvolvement KD (n = 284) and coronary artery involvement KD (n = 29). Blood samples were collected within 24-h pre-IVIG therapy and 48-h post-IVIG therapy. Coagulation profiles, conventional inflammatory mediators and blood cell counts were detected. Echocardiography was performed during the period from 2- to 14-day post-IVIG infusion. In addition, 315 sex- and age-matched healthy children were enrolled as the controls. (1) Before IVIG therapy, coagulation disorders were more prone to appear in KD patients than in healthy controls, and could be overcome by IVIG therapy. FIB and DD significantly increased in the acute phase of KD, whereas reduced to normal levels after IVIG therapy. (2) PT and APTT were significantly longer in patients with complete KD when compared with their incomplete counterparts after IVIG therapy. (3) The larger δDD, δFDP and the smaller δPT, δINR predicted IVIG nonresponsiveness. (4) The higher δDD and δFDP correlated with a higher risk for CAAs (DD: r = -0.72, FDP: r = -0.54). Coagulation disorders are correlated with complete phenotype, IVIG nonresponsiveness and CAA occurrence in the acute episode of KD, and can be rectified by synergistic effects of IVIG and aspirin.
凝血障碍在川崎病(KD)中很常见。本研究的主要目的是探讨凝血谱与临床分类、IVIG 反应性、KD 急性期冠状动脉异常(CAA)的关系。共招募 313 例 KD 患儿,分为 6 个亚组,包括完全 KD(n=217)、不完全 KD(n=96)、IVIG 反应性 KD(n=293)、IVIG 非反应性 KD(n=20)、无冠状动脉受累 KD(n=284)和冠状动脉受累 KD(n=29)。在 IVIG 治疗前 24 小时内和 IVIG 治疗后 48 小时内采集血样。检测凝血谱、常规炎症介质和血细胞计数。在 IVIG 输注后 2-14 天进行超声心动图检查。此外,还招募了 315 名性别和年龄匹配的健康儿童作为对照组。(1)在 IVIG 治疗前,KD 患儿比健康对照更易出现凝血障碍,且 IVIG 治疗可纠正凝血障碍。KD 急性期 FIB 和 DD 显著增加,IVIG 治疗后降至正常水平。(2)IVIG 治疗后,完全 KD 患者的 PT 和 APTT 明显长于不完全 KD 患者。(3)较大的 δDD、δFDP 和较小的 δPT、δINR 预测 IVIG 无反应性。(4)较高的 δDD 和 δFDP 与 CAA 发生的风险增加相关(DD:r=-0.72,FDP:r=-0.54)。在 KD 急性期,凝血障碍与完全表型、IVIG 无反应性和 CAA 发生有关,且可通过 IVIG 和阿司匹林的协同作用得到纠正。